wolf-001

$XTALPI(02228.HK) Can it stabilize above the line today? Now we need some luck.

$XTALPI(02228.HK) There's one more short-selling tool available on August 31st, looking forward to it!

$XTALPI(02228.HK)The ticket for AI drug development has risen to $400 million each. A company called chai discovery, which was founded just 18 months ago, just secured $400 million in funding, with a post-investment valuation of $3.8 billion!

$XTALPI(02228.HK) Sigene Biotech, in-depth principles, Yaosu Technology did a great job

$XTALPI(02228.HK)

Mist veils the path, the road ahead is cut off,

Intelligent deduction never ceases.

Through trial and error, new dimensions are explored,

A beam of bright light guides the distant track.

$XTALPI(02228.HK)@Jianghan Nanjing Has Mr. Zhou closed out his position yet?

$XTALPI(02228.HK) feels like Jingtai is a bit anxious, but it might be bound by a non-disclosure agreement and have no way out

$XTALPI(02228.HK) will be very interesting today

$XTALPI(02228.HK) This thing goes up and down by two dollars, it's like playing house.

$XTALPI(02228.HK) Agilent's global CEO led a core executive team to visit Jingtai Technology, jointly envisioning a new collaborative blueprint of "brain, hand, eye" for the AI4S era. Automated experimental equipment holds promising future prospects!

$XTALPI(02228.HK) YAOZU Technology, a global leading "AI+organ-on-a-chip" enabled new drug R&D platform company incubated by Jingtai Technology (2228.HK), announced the completion of nearly RMB 200 million in A+ round financing. This round of financing was jointly participated by Guofang Venture Capital, Qingsong Capital, GF Xinde, Oriental Fortune Capital, and Yunbo Capital, with existing shareholder Yayi Capital continuing to increase its investment. This is another major financing event following the completion of over RMB 200 million in Series A financing led by China Life Equity Investment and with continued investment from existing shareholders like Jingtai Technology earlier this year. So far, YAOZU Technology has cumulatively completed nearly RMB 400 million in Series A financing, further consolidating its leading position in the AI for Biology track based on artificial intelligence and organ-on-a-chip technology.

$XTALPI(02228.HK) Regarding this CEO's underhanded behavior, the big retail investors voted with their feet today!

$XTALPI(02228.HK) It's over, it's been screenshotted and posted on Xueqiu, I'm sorry Mr. Lu!

$XTALPI(02228.HK) Today, Little Jingjing and Little Yingzi appeared together on CCTV-2's prime-time program "Economic Half-Hour"! They were featured extensively, along with several other smaller companies related to Jingtai. The company's fundamental narrative is getting stronger. However, the management's capital market operations are eroding trust!

$XTALPI(02228.HK) Dr. Ma lost 9.224 million shares, who picked them up!

$XTALPI(02228.HK) The short position is very strong today, but the long position seems to be on steroids, like an unkillable cockroach!

$XTALPI(02228.HK) Just found out that the Hang Seng Tech Index and the A-shares have converged. How are you guys doing this year with the Hang Seng Tech, innovative drugs, and old-man stocks? Getting hit from both sides?

$XTALPI(02228.HK) Shorts still managed to trade 9 million shares today, not bad, keep it up, they can still manage 50 to 100 million shares in a week! Open interest can reach 450 to 500 million shares

$XTALPI(02228.HK) Where are the shorts today? Hurry up, there's only an hour left, time is running out.

$XTALPI(02228.HK) The short sellers weren't strong enough this afternoon, still haven't reached 10 million shares, let's go tomorrow!

$XTALPI(02228.HK) I'm just curious about how much borrowable stock is left? The short interest ratio has basically reached 10%! Founder team holdings plus locked positions from Stock Connect plus some long-term ETFs that don't move, has the actual effective proportion already reached around 30%? The float is already exhausted, basically maintained by short selling!

$XTALPI(02228.HK)The top 30 list for the WAIC conference's highest honor, the SAIL Award, has been officially announced. "Deep Principle" successfully made the cut into this authoritative list, often called the "Oscars" of the world's AI community, standing out from 230 top global projects with its "AI Scientist Platform: Closed-loop Innovation for Industrial R&D."

$XTALPI(02228.HK)Canceled the order at just 5.6?

$XTALPI(02228.HK) On Tuesday's close, Southbound capital increased its holdings by 5.128 million shares of Jingtai Holdings (02228.HK). In the past 5 trading days, it saw Southbound capital buying on 3 days, with a cumulative net increase of 30.9671 million shares. In the past 20 trading days, it saw Southbound capital buying on 10 days, with a cumulative net increase of 59.5312 million shares. As of now, Southbound capital holds 2.04 billion shares of Jingtai Holdings (02228.HK), accounting for 47.4% of the company's issued ordinary shares. With so much Southbound buying, where is the reduction coming from!